BioSpace News Archive

Business

Gilead Sciences to Release Third Quarter 2019 Financial Results on Thursday, October 24, 2019

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2019 financial results will be released on Thursday, October 24, after the market closes.

October 10, 2019
·
1 min read
Business

Albert Einstein College of Medicine and CUNY School of Public Health Collaborate to Offer Medical Students M.D./M.P.H. Program

Einstein is initially offering this opportunity to the Class of 2023 and will make it available to all subsequent incoming M.D. students.

October 10, 2019
·
5 min read
Deals

Canavation Product Group Acquires Consumer Product Division From Teewinot Life Sciences

Terms of the deal were not publicly disclosed.

October 10, 2019
·
4 min read
Deals

Therapix Biosciences Provides Update on Planned Merger With Destiny Biosciences Global Corp.

Therapix Biosciences Ltd. (“Therapix” or the “Company”) (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today an update on its planned merger with Destiny Biosciences Global Corp. (“Destiny”).

October 10, 2019
·
3 min read
Biotech Bay

Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration

KSI-301, in patients with treatment-naïve wet age-related macular degeneration

October 10, 2019
·
6 min read
Biotech Bay

Vir Biotechnology Announces Pricing of Initial Public Offering

Vir has granted the underwriters a 30-day option to purchase up to 1,071,428 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.

October 10, 2019
·
3 min read
Business

Fred Moll Named Chairman of the Board at MIVI Neuroscience

Dr. Moll has founded or co-founded multiple innovative medical device companies, and has served on numerous boards throughout his career.

October 10, 2019
·
2 min read
Biotech Beach

MedTech Innovator Names NDR Medical as 2019 Asia Pacific Competition Winner at The MedTech Forum

Startup Receives $150K Grand Prize for Artificial Intelligence-Driven Robotics System to Expedite Diagnosis of Critical Illnesses

October 10, 2019
·
4 min read
Drug Development

Mezzion Pharma announces that it has conducted a Type C Meeting with the FDA Regarding the TOP Line Data from the FUEL Phase 3 Clinical Trial

The purpose of the Type C meeting was to receive FDA guidance on Mezzion’s NDA submission.

October 10, 2019
·
3 min read